| scholarly article | Q13442814 |
| P50 | author | Sandra Orchard | Q47503082 |
| P2093 | author name string | Davis PD | |
| Elliott LH | |||
| Hill CH | |||
| Lawton G | |||
| Wilkinson SE | |||
| Wadsworth J | |||
| Dale MM | |||
| Kumar H | |||
| Muid RE | |||
| Twomey BM | |||
| P2860 | cites work | Studies with protein kinase C inhibitors presently available cannot elucidate the role of protein kinase C in the activation of NADPH oxidase. | Q53042404 |
| The interleukin-2 T-cell system: a new cell growth model. | Q55062562 | ||
| Potent selective inhibitors of protein kinase C | Q57005076 | ||
| The role of protein kinase C in cell surface signal transduction and tumour promotion | Q29618532 | ||
| Calcium influx stimulates a second pathway for sustained diacylglycerol production in leukocytes activated by chemoattractants | Q33557357 | ||
| K252a is a potent and selective inhibitor of phosphorylase kinase | Q34655234 | ||
| K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases | Q34684562 | ||
| Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes. | Q36258532 | ||
| Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease | Q40002259 | ||
| Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation | Q40921675 | ||
| The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst | Q41201640 | ||
| Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase | Q42216028 | ||
| Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil | Q42543312 | ||
| The effect of putative protein kinase C inhibitors, K252a and staurosporine, on the human neutrophil respiratory burst activated by both receptor stimulation and post-receptor mechanisms | Q42563267 | ||
| Stimulation of phosphorylcholine turnover and diacylglycerol production in human polymorphonuclear leukocytes. Novel assay for phosphorylcholine | Q42836468 | ||
| The protein kinase C inhibitors H-7 and H-9 fail to inhibit human neutrophil activation | Q46299642 | ||
| Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases | Q48791313 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 169-172 | |
| P577 | publication date | 1991-11-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli | |
| P478 | volume | 293 |
| Q41408757 | A cell-based reporter assay for the identification of protein kinase C activators and inhibitors |
| Q33698833 | A novel protein kinase target for the lipid second messenger phosphatidic acid |
| Q27321219 | A small-molecule screen for enhanced homing of systemically infused cells |
| Q40896788 | Activation and tyrosine phosphorylation of protein kinase C delta in response to B cell antigen receptor stimulation |
| Q31140832 | Approaches to study posttranslational regulation of intermediate filament proteins. |
| Q41943052 | Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes |
| Q73149488 | Different sensitivities of neutrophil responses to a selective protein kinase C inhibitor Ro 31-8425; redundancy in signal transduction |
| Q72285870 | Effect of a selective protein kinase C inhibitor, Ro 31-8425, on Mac-1 expression and adhesion of human neutrophils |
| Q28365354 | Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors |
| Q28269137 | Fcgamma receptor signaling in phagocytes |
| Q36780383 | Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization |
| Q33744100 | Inhibition of development of Myxococcus xanthus by eukaryotic protein kinase inhibitors |
| Q42017361 | Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C |
| Q51543526 | Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. |
| Q43038640 | Participation of protein kinases in staurosporine-induced interleukin-6 production by rat peritoneal macrophages |
| Q46776698 | Pityriarubins, novel highly selective inhibitors of respiratory burst from cultures of the yeast Malassezia furfur: comparison with the bisindolylmaleimide arcyriarubin A. |
| Q28569384 | Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors |
| Q42122867 | Protein kinase C activity is not involved in N-formylmethionyl-leucyl-phenylalanine-induced phospholipase D activation in human neutrophils, but is essential for concomitant NADPH oxidase activation: studies with a staurosporine analogue with improv |
| Q43847513 | Protein kinase C increases 11beta-hydroxysteroid dehydrogenase oxidation and inhibits reduction in rat Leydig cells |
| Q72508371 | Protein kinase C is not a downstream effector of p21ras in activated T cells |
| Q38342490 | Regulation of clusterin gene expression by transforming growth factor beta |
| Q40900661 | Therapeutic potential of protein kinase C inhibitors |
| Q33574672 | mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. |
Search more.